SCHEMBL7969489

SCHEMBL7969489

Cc1cccc(Cl)c1Nc1nc2cc(OCCN3CCOCC3)c(N3C[C@@H](C)N[C@@H](C)C3)cc2n2cncc12

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.75
SRC P12931 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969486 1.00 LCK (0.75) LCKSRC
SCHEMBL7970031 0.90 LCK (0.78) LCKSRC
SCHEMBL7983711 0.89 LCK (0.94) LCKSRC
SCHEMBL7987018 0.87 LCK (0.76) LCKSRC
SCHEMBL7981749 0.86 LCK (0.74) LCK
SCHEMBL7970375 0.86 LCK (0.89) LCKSRC
SCHEMBL7980325 0.86 LCK (1.00) LCK
SCHEMBL7987001 0.86 LCK (1.00) LCK
SCHEMBL7970240 0.85 LCK (0.69) LCKSRC
SCHEMBL7983576 0.85 LCK (1.00) LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed